Search research articles
Contact Us
Filters
Showing results (51-60 of 80) with videos related to
Page
of 8
Sort By:
The Journal of Biological Chemistry
|
August 15, 2003
Alternative splicing of the human cyclin D-binding Myb-like protein (hDMP1) yields a truncated protein isoform that alters macrophage differentiation patterns
Mario P Tschan, Kimberlee M Fischer, Vivian S Fung, et al.
Proteomics
|
July 18, 2009
Novel functional profiling approach combining reverse phase protein microarrays and human 3-D ex vivo tissue cultures: expression of apoptosis-related proteins in human colon cancer
Farzaneh Pirnia, Michael Pawlak, Gerhard G Thallinger, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
October 1, 1994
First isolated locoregional recurrence following mastectomy for breast cancer: results of a phase III multicenter study comparing systemic treatment with observation after excision and radiation. Swiss Group for Clinical Cancer Research
M Borner, M Bacchi, A Goldhirsch, et al.
European Journal of Cancer (Oxford, England : 1990)
|
March 10, 1999
Cisplatin, doxorubicin and etoposide (PAV) in advanced gastric carcinoma: the SAKK experience. Swiss Group for Clinical Cancer Research (SAKK)
A D Roth, R Herrmann, R Morant, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
April 28, 2004
5-Fluorouracil as protracted continuous intravenous infusion can be added to full-dose docetaxel (Taxotere)-cisplatin in advanced gastric carcinoma: a phase I-II trial
A D Roth, R Maibach, N Fazio, et al.
European Journal of Cancer (Oxford, England : 1990)
|
December 2, 2004
Phase II study of OSI-211 (liposomal lurtotecan) in patients with metastatic or loco-regional recurrent squamous cell carcinoma of the head and neck. An EORTC New Drug Development Group study
F Duffaud, M Borner, P Chollet, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
February 5, 1999
Phase I clinical and pharmacokinetic study of the oral platinum analogue JM216 given daily for 14 days
C Sessa, C Minoia, A Ronchi, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
July 8, 1998
The impact of adding low-dose leucovorin to monthly 5-fluorouracil in advanced colorectal carcinoma: results of a phase III trial. Swiss Group for Clinical Cancer Research (SAKK)
M M Borner, M Castiglione, M Bacchi, et al.
British Journal of Cancer
|
March 10, 1999
Expression of apoptosis regulatory proteins of the Bcl-2 family and p53 in primary resected non-small-cell lung cancer
M M Borner, P Brousset, B Pfanner-Meyer, et al.
European Journal of Cancer (Oxford, England : 1990)
|
October 26, 2001
Phase II trial with ISIS 5132 in patients with small-cell (SCLC) and non-small cell (NSCLC) lung cancer. A European Organization for Research and Treatment of Cancer (EORTC) Early Clinical Studies Group report
B Coudert, A Anthoney, W Fiedler, et al.
Page
of 8
Search research articles
Search
Showing results (51-60 of 80) with videos related to
Sort By:
Page
of 8
The Journal of Biological Chemistry
|
August 15, 2003
Alternative splicing of the human cyclin D-binding Myb-like protein (hDMP1) yields a truncated protein isoform that alters macrophage differentiation patterns
Mario P Tschan, Kimberlee M Fischer, Vivian S Fung, et al.
Proteomics
|
July 18, 2009
Novel functional profiling approach combining reverse phase protein microarrays and human 3-D ex vivo tissue cultures: expression of apoptosis-related proteins in human colon cancer
Farzaneh Pirnia, Michael Pawlak, Gerhard G Thallinger, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
October 1, 1994
First isolated locoregional recurrence following mastectomy for breast cancer: results of a phase III multicenter study comparing systemic treatment with observation after excision and radiation. Swiss Group for Clinical Cancer Research
M Borner, M Bacchi, A Goldhirsch, et al.
European Journal of Cancer (Oxford, England : 1990)
|
March 10, 1999
Cisplatin, doxorubicin and etoposide (PAV) in advanced gastric carcinoma: the SAKK experience. Swiss Group for Clinical Cancer Research (SAKK)
A D Roth, R Herrmann, R Morant, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
April 28, 2004
5-Fluorouracil as protracted continuous intravenous infusion can be added to full-dose docetaxel (Taxotere)-cisplatin in advanced gastric carcinoma: a phase I-II trial
A D Roth, R Maibach, N Fazio, et al.
European Journal of Cancer (Oxford, England : 1990)
|
December 2, 2004
Phase II study of OSI-211 (liposomal lurtotecan) in patients with metastatic or loco-regional recurrent squamous cell carcinoma of the head and neck. An EORTC New Drug Development Group study
F Duffaud, M Borner, P Chollet, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
February 5, 1999
Phase I clinical and pharmacokinetic study of the oral platinum analogue JM216 given daily for 14 days
C Sessa, C Minoia, A Ronchi, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
July 8, 1998
The impact of adding low-dose leucovorin to monthly 5-fluorouracil in advanced colorectal carcinoma: results of a phase III trial. Swiss Group for Clinical Cancer Research (SAKK)
M M Borner, M Castiglione, M Bacchi, et al.
British Journal of Cancer
|
March 10, 1999
Expression of apoptosis regulatory proteins of the Bcl-2 family and p53 in primary resected non-small-cell lung cancer
M M Borner, P Brousset, B Pfanner-Meyer, et al.
European Journal of Cancer (Oxford, England : 1990)
|
October 26, 2001
Phase II trial with ISIS 5132 in patients with small-cell (SCLC) and non-small cell (NSCLC) lung cancer. A European Organization for Research and Treatment of Cancer (EORTC) Early Clinical Studies Group report
B Coudert, A Anthoney, W Fiedler, et al.
Page
of 8